TEL AVIV, Israel, June 3, 2024 /CNW/ — Zero Candida (the “Company” or “ZC “) an Israeli FemTech medical device start-up is pleased to announce that it is in the process of applying to the TSX Venture Exchange in Canada to list its shares at a proposed valuation of 40 million Canadian dollars.
- Zero Candida
Zero Candida Announces its Intent to Complete Listing of its Shares on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars
Public Announcements
- Zero Candida
Zero Candida Announces its Intent to Complete Listing of its Shares on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars
TEL AVIV, Israel, June 3, 2024 /CNW/ — Zero Candida (the “Company” or “ZC “) an Israeli FemTech medical device start-up is pleased to announce…
- Zero Candida
Zero Candida Announces First Intellectual Property in South Africa
Company is in the process to be listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars TEL AVIV,…
- Zero Candida
Zero Candida Announces First Intellectual Property in South Africa
Company is in the process to be listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars TEL AVIV,…
